학술논문
111 - Real-world outcomes using pembrolizumab plus pemetrexed-platinum in 1st line metastatic NSCLC compared to results reported from KEYNOTE-189: a multicentre experience.
Document Type
Article
Author
Source
Subject
*PEMBROLIZUMAB
*NON-small-cell lung carcinoma
*METASTASIS
*
*
Language
ISSN
0169-5002